Vincenza Snow, MD; Kevin B. Weiss, MD; Christel Mottur-Pilson, PhD; for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians*
* This paper, written by Vincenza Snow, MD, Kevin B. Weiss, MD, and Christel Mottur-Pilson, PhD, was developed by the Clinical Efficacy Assessment Subcommittee of the American College of Physicians (ACP): Kevin Weiss, MD (Chair); Mark Aronson, MD; Patricia Barry, MD; Nick Fitterman, MD; E. Rodney Hornbake, MD; Keith Michl, MD; Doug Owens, MD; Allan Ronald, MD; and Katherine Sherif, MD. This manuscript was peer reviewed by the American Diabetes Association, the National Diabetes Education Program (National Heart, Lung, and Blood Institute), and the American Academy of Family Physicians. Approved by the ACP Board of Regents in October 2001.
Annals of Internal Medicine encourages readers to copy and distribute this paper, providing such distribution is not for profit. Commercial distribution is not permitted without the express permission of the publisher.
In memory of Herbert S. Waxman, MD, Senior Vice President of the Medical Knowledge and Education Division of the American College of Physicians. The members of the Clinical Efficacy Assessment Subcomittee and the staff of the Scientific Policy Department will miss Dr. Waxman's wisdom and leadership. It was an honor to work with him.
Note: Clinical practice guidelines are guides only and may not apply to all patients and all clinical situations. Thus, they are not intended to override clinicians' judgment. All ACP clinical practice guidelines are considered automatically withdrawn or invalid 5 years after publication or once an update has been issued.
Grant Support: Financial support for ACP guideline development comes exclusively from the ACP operating budget.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Vincenza Snow, MD, American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106; e-mail, email@example.com.
Current Author Addresses: Drs. Snow and Mottur-Pilson: American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106.
Dr. Weiss: 676 North St. Clair Street, Suite 200, Chicago, IL 60611.
Table. Number Needed To Treat for Benefit for Tight Hypertension Control in the United Kingdom Prospective Diabetes Study
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Snow V, Weiss KB, Mottur-Pilson C, for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians*. The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus. Ann Intern Med. 2003;138:587–592. doi: 10.7326/0003-4819-138-7-200304010-00017
Download citation file:
Published: Ann Intern Med. 2003;138(7):587-592.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Guidelines.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use